These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8503601)
1. Interview with Norman Talal. What is going to happen tomorrow as far as Sjögren's syndrome is concerned? Talal N Ann Med Interne (Paris); 1993; 144(1):21-2. PubMed ID: 8503601 [No Abstract] [Full Text] [Related]
2. Interview with Joaquim Coll. What is going to happen tomorrow as far as secondary Sjögren's syndrome is concerned?. Interview by P. Youinou. Coll J Ann Med Interne (Paris); 1993; 144(4):257-9. PubMed ID: 8368718 [No Abstract] [Full Text] [Related]
3. Interview with Haralampos M. Moutsopoulos. What's going to happen as far as the natural history of Sjögren's syndrome is concerned?. Interview by Pierre Youinou. Moutsopoulos HM Ann Med Interne (Paris); 1994; 145(3):175-6. PubMed ID: 8092631 [No Abstract] [Full Text] [Related]
4. The possible etiopathogenic genes of Sjögren's syndrome. Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615 [TBL] [Abstract][Full Text] [Related]
6. Primary Sjögren's syndrome: current and emergent aetiopathogenic concepts. Ramos-Casals M; Font J Rheumatology (Oxford); 2005 Nov; 44(11):1354-67. PubMed ID: 15956090 [No Abstract] [Full Text] [Related]
7. The international symposium on Sjögren's syndrome in Brest: the "top of the tops" at the "tip of the tips". Youinou P; Pers JO Autoimmun Rev; 2010 Jul; 9(9):589-90. PubMed ID: 20493281 [No Abstract] [Full Text] [Related]
9. [Sjögren's syndrome: current concept]. Sánchez y Sánchez ML An Med Interna; 1994 Aug; 11(8):369-71. PubMed ID: 7772681 [No Abstract] [Full Text] [Related]
11. Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma. Folli F; Perego L; Ponzoni M; Girardi AM; Bosi E; Ferreri AJ; Bellone M; Sabbadini MG; Vicari AM; Trusolino L Ann Hematol; 2002 Oct; 81(10):597-602. PubMed ID: 12424543 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus and Sjögren's syndrome: trigger or mimic? Ramos-Casals M; Muñoz S; Zerón PB Rheum Dis Clin North Am; 2008 Nov; 34(4):869-84, vii. PubMed ID: 18984409 [TBL] [Abstract][Full Text] [Related]
13. [Etiopathogenesis of Sjögren's syndrome]. Solans R; Labrador M; Angel Bosch J Med Clin (Barc); 2001 May; 116(19):750-5. PubMed ID: 11412699 [No Abstract] [Full Text] [Related]
14. Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going? Dawson L; Tobin A; Smith P; Gordon T Arthritis Rheum; 2005 Oct; 52(10):2984-95. PubMed ID: 16200578 [No Abstract] [Full Text] [Related]
15. [Molecular mechanism in Sjögren syndrome: T cell receptors and autoantigens]. Sumida T Ryumachi; 2002 Oct; 42(5):769-76. PubMed ID: 12465594 [No Abstract] [Full Text] [Related]
17. Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome. Soyfoo MS; Steinfeld S; Delporte C Oral Dis; 2007 Jul; 13(4):366-75. PubMed ID: 17577322 [TBL] [Abstract][Full Text] [Related]
18. [Gougerot-Sjögren syndrome: the viruses in the box of the accused]. Moutsopoulos H; Papadopoulos G; Youinou P Ann Med Interne (Paris); 1994; 145(1):25-31. PubMed ID: 8192277 [No Abstract] [Full Text] [Related]